In vivo targeting of lentiviral vectors pseudotyped with the Tupaia paramyxovirus H glycoprotein bearing a cell-specific ligand.
Argaw T, Marino MP, Timmons A, Eldridge L, Takeda K, Li P, Kwilas A, Ou W, Reiser J
Mol Ther Methods Clin Dev. 2021 Apr 24;21:670-680. doi: 10.1016/j.omtm.2021.04.012. eCollection 2021 Jun 11. PubMed Article
Argaw T, Marino MP, Timmons A, Eldridge L, Takeda K, Li P, Kwilas A, Ou W, Reiser J
Mol Ther Methods Clin Dev. 2021 Apr 24;21:670-680. doi: 10.1016/j.omtm.2021.04.012. eCollection 2021 Jun 11. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 163869 | pCG-TPMV Hd32-IL-13 | Expresses TPMV H glycoprotein bearing IL-13 in mammalian cells |
| 163963 | pCG-TPMV Hd32 | Expresses TPMV H glycoprotein in mammalian cells |
| 163964 | pCG-TPMV Fd32 | Expression of TPMV F glycoprotein in mammalian cells |
| 163965 | pNL(CMV)TK2ALuc2/CMV/WPREdU3 | Co-expression of HSV-1 TK and firefly luciferase in mammalian cells |